Van Plew Daniel P 4
4 · REGENERON PHARMACEUTICALS, INC. · Filed Feb 16, 2024
Insider Transaction Report
Form 4
Van Plew Daniel P
EVP & General Mgr, Industrial
Transactions
- Sale
Common Stock
[F1]2024-02-14$937.94/sh−439$411,756→ 30,373 total - Sale
Common Stock
[F2]2024-02-14$938.13/sh−226$212,017→ 30,147 total - Sale
Common Stock
[F3]2024-02-14$939.60/sh−750$704,700→ 29,397 total - Sale
Common Stock
[F4]2024-02-14$940.44/sh−4,261$4,007,215→ 25,136 total - Sale
Common Stock
[F5]2024-02-14$941.41/sh−275$258,888→ 24,861 total - Sale
Common Stock
[F6]2024-02-14$943.51/sh−2,691$2,538,985→ 22,170 total - Sale
Common Stock
[F7]2024-02-14$944.30/sh−620$585,466→ 21,550 total - Sale
Common Stock
[F8]2024-02-14$945.81/sh−95$89,852→ 21,455 total - Sale
Common Stock
[F9]2024-02-14$947.81/sh−240$227,474→ 21,215 total - Sale
Common Stock
[F10]2024-02-14$948.70/sh−150$142,305→ 21,065 total - Sale
Common Stock
[F11]2024-02-14$949.07/sh−112$106,296→ 20,953 total - Sale
Common Stock
[F12]2024-02-14$950.45/sh−375$356,419→ 20,578 total - Sale
Common Stock
[F13]2024-02-14$951.77/sh−200$190,354→ 20,378 total
Holdings
- 12,376(indirect: 2023 GRAT)
Common Stock
- 1,084(indirect: By 401(k))
Common Stock
Footnotes (13)
- [F1]Represents volume-weighted average price of sales of 439 shares of Company stock on February 14, 2024 at prices ranging from $937.86 to $937.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- [F10]Represents volume-weighted average price of sales of 150 shares of Company stock on February 14, 2024 at prices ranging from $948.13 to $948.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- [F11]Represents volume-weighted average price of sales of 112 shares of Company stock on February 14, 2024 at prices ranging from $949.02 to $949.14. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- [F12]Represents volume-weighted average price of sales of 375 shares of Company stock on February 14, 2024 at prices ranging from $950.37 to $950.55. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- [F13]Represents volume-weighted average price of sales of 200 shares of Company stock on February 14, 2024 at prices ranging from $951.61 to $951.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- [F2]Represents volume-weighted average price of sales of 226 shares of Company stock on February 14, 2024 at prices ranging from $938.00 to $938.45. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- [F3]Represents volume-weighted average price of sales of 750 shares of Company stock on February 14, 2024 at prices ranging from $939.39 to $939.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- [F4]Represents volume-weighted average price of sales of 4,261 shares of Company stock on February 14, 2024 at prices ranging from $940.06 to $940.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- [F5]Represents volume-weighted average price of sales of 275 shares of Company stock on February 14, 2024 at prices ranging from $941.09 to $941.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- [F6]Represents volume-weighted average price of sales of 2,691 shares of Company stock on February 14, 2024 at prices ranging from $943.23 to $943.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- [F7]Represents volume-weighted average price of sales of 620 shares of Company stock on February 14, 2024 at prices ranging from $944.29 to $944.30. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- [F8]Represents volume-weighted average price of sales of 95 shares of Company stock on February 14, 2024 at prices ranging from $945.66 to $945.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- [F9]Represents volume-weighted average price of sales of 240 shares of Company stock on February 14, 2024 at prices ranging from $947.77 to $947.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
Signature
/s/**Daniel P. Van Plew|2024-02-16